Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Sugawara Y, Inomata Y. Indications for living donor liver transplantation in patients with hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2016;5(5):429–432. doi:10.21037/hbsn.2016.09.01
   PubMed Web of Science ®Google Scholar
• Simmerman E, Chung J, Lawson A, et al. Application of irreversible electroporation ablation as adjunctive treatment for margin enhancement: safety and efficacy. J Surg Res. 2020;246:260–268. doi:10.1016/j.jss.2019.06.010
   PubMed Web of Science ®Google Scholar
• Vitale A, Peck-Radosavljevic M, Giannini EG, et al. Personalized treatment of patients with very early hepatocellular carcinoma. J Hepatol. 2017;66(2):412–423. doi:10.1016/j.jhep.2016.09.012
   PubMed Web of Science ®Google Scholar
• Galle PR, Forner A, Llovet JM, et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Raoul JL, Schirmacher P, Vilgrain V. Corrigendum to “EASL clinical practice guidelines: management of hepatocellular carcinoma” [J Hepatol 69 (2018) 182–236]. J Hepatol. 2019;70(4):817.
   PubMed Web of Science ®Google Scholar
• Habibollahi P, Sheth RA, Cressman ENK. Histological correlation for radiofrequency and microwave ablation in the local control of hepatocellular carcinoma (HCC) before liver transplantation: a comprehensive review. Cancers. 2020;13(1):104. doi:10.3390/cancers13010104
   PubMed Web of Science ®Google Scholar
• Bae SH, Park HC. Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy. Ann Transl Med. 2018;6(Suppl 1):S3. doi:10.21037/atm.2018.08.28
   PubMedGoogle Scholar
• Donaldson K, Buchanich JM, Grigson PS. Abstracts of presentations at the association of clinical scientists 143rd meeting Louisville, KY May 11–14, 2022. Ann Clin Lab Sci. 2022;52(3):511–525.
   PubMedGoogle Scholar
• Xu C, Li L, Xu W, et al. Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results. Int J Hyperthermia. 2019;36(1):351–358. doi:10.1080/02656736.2019.1571247
   PubMed Web of Science ®Google Scholar
• Domini J, Makary MS. Single-center analysis of percutaneous ablation in the treatment of hepatocellular carcinoma: long-term outcomes of a 7-year experience. Abdom Radiol. 2023;48(3):1173–1180. doi:10.1007/s00261-023-03819-y
   PubMed Web of Science ®Google Scholar
• Majumdar A, Roccarina D, Thorburn D, et al. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis. Cochrane Database Syst Rev. 2017;3(3):CD011650. doi:10.1002/14651858.CD011650.pub2
   PubMedGoogle Scholar
• Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33(1):62–68. doi:10.1159/000454697
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–571. doi:10.1097/SLA.0000000000003268
   PubMed Web of Science ®Google Scholar
• Shindoh J. Stratification of risk of recurrence after curative-intent treatment for small hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2019;8(6):649–650. doi:10.21037/hbsn.2019.07.17
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen W, Mai W, et al. HIF-2α regulates proliferation, invasion, and metastasis of hepatocellular carcinoma cells via VEGF/Notch1 signaling axis after insufficient radiofrequency ablation. Front Oncol. 2022;12:998295. doi:10.3389/fonc.2022.998295
   PubMed Web of Science ®Google Scholar
• Xiao C, Liu S, Ge G, et al. Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies. Front Pharmacol. 2023;14:1086813. doi:10.3389/fphar.2023.1086813
   PubMed Web of Science ®Google Scholar
• Pausch A-M, Ghali T, Wertheimer T, et al. Stereotactic microwave ablation of hepatocellular carcinoma: the impact of tumor size and minimal ablative margin on therapeutic success. Tomography. 2022;9(1):50–59. doi:10.3390/tomography9010005
   PubMed Web of Science ®Google Scholar
• Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24(10):e990–e1005. doi:10.1634/theoncologist.2018-0337
   PubMed Web of Science ®Google Scholar
• Evans AL, Ma C, Hagness SC. Microwave-induced thermoacoustic signal characteristics in a dynamic temperature environment. Biomed Phys Eng Express. 2022;8(3):035020. doi:10.1088/2057-1976/ac60c6
   Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled Phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317–325. doi:10.1016/S2468-1253(18)30029-3
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Nour-Eldin N-EA, Hammerstingl RM, et al. Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms - review article. RoFo. 2017;189(11):1055–1066. doi:10.1055/s-0043-117410
   PubMedGoogle Scholar
• Wang Z, Liu M, Zhang D-Z, et al. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3–5-cm HCC. Hepatology. 2022;76(1):66–77. doi:10.1002/hep.32323
   PubMed Web of Science ®Google Scholar
• Makovich Z, Logemann J, Chen L, et al. Liver tumor ablation in difficult locations: microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2021;71:170–177. doi:10.1016/j.clinimag.2020.11.010
   PubMed Web of Science ®Google Scholar
• An C, Li X, Zhang M, et al. 3D visualization ablation planning system assisted microwave ablation for hepatocellular carcinoma (Diameter >3): a precise clinical application. BMC Cancer. 2020;20(1):44. doi:10.1186/s12885-020-6519-y
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019;13(2):125–137. doi:10.1007/s12072-018-9919-1
   PubMed Web of Science ®Google Scholar
• Hermida M, Cassinotto C, Piron L, et al. Multimodal percutaneous thermal ablation of small hepatocellular carcinoma: predictive factors of recurrence and survival in western patients. Cancers. 2020;12(2):1.
   Web of Science ®Google Scholar
• Swan RZ, Sindram D, Martinie JB, et al. Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes. J Gastrointest Surg. 2013;17(4):719–729. doi:10.1007/s11605-013-2164-y
   PubMed Web of Science ®Google Scholar
• Sun A-X, Cheng Z-L, Wu -P-P, et al. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation. World J Gastroenterol. 2015;21(10):2997–3004. doi:10.3748/wjg.v21.i10.2997
   PubMed Web of Science ®Google Scholar
• Zhang -T-T, Luo H-C, Cui X, et al. Ultrasound-guided percutaneous microwave ablation treatment of initial recurrent hepatocellular carcinoma after hepatic resection: long-term outcomes. Ultrasound Med Biol. 2015;41(9):2391–2399. doi:10.1016/j.ultrasmedbio.2015.04.019
   PubMed Web of Science ®Google Scholar
• Baker EH, Thompson K, McKillop IH, et al. Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients. J Gastrointest Oncol. 2017;8(2):337–346. doi:10.21037/jgo.2016.09.06
   PubMed Web of Science ®Google Scholar
• Yin T, Li W, Zhao P, et al. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma. Clin Radiol. 2017;72(2):136–140. doi:10.1016/j.crad.2016.10.022
   PubMed Web of Science ®Google Scholar
• Ma S, Ding M, Li J, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol. 2017;143(1):131–142. doi:10.1007/s00432-016-2266-5
   PubMed Web of Science ®Google Scholar
• Jin T, Liu X, Zhang H, et al. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a propensity score matching analysis. Int J Hyperthermia. 2020;37(1):955–964. doi:10.1080/02656736.2020.1804076
   PubMed Web of Science ®Google Scholar
• Potretzke TA, Ziemlewicz TJ, Hinshaw JL, et al. Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center. J Vasc Interv Radiol. 2016;27(5):631–638. doi:10.1016/j.jvir.2016.01.136
   PubMed Web of Science ®Google Scholar
• Feng H, Yang C, Xu F, et al. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis. Eur J Surg Oncol. 2022;48(2):418–424. doi:10.1016/j.ejso.2021.08.035
   PubMed Web of Science ®Google Scholar
• Ryu T, Takami Y, Wada Y, et al. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: a propensity score-matched analysis. Surgery. 2019;166(3):254–262. doi:10.1016/j.surg.2019.05.007
   PubMed Web of Science ®Google Scholar
• Zhang M, Ma H, Zhang J, et al. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis. Onco Targets Ther. 2017;10:4829–4839. doi:10.2147/OTT.S141968
   PubMed Web of Science ®Google Scholar
• Glassberg MB, Ghosh S, Clymer JW, et al. Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):98. doi:10.1186/s12957-019-1632-6
   PubMed Web of Science ®Google Scholar
• Wang ZL, Liang P, Dong BW, et al. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg. 2008;12(2):327–337. doi:10.1007/s11605-007-0310-0
   PubMed Web of Science ®Google Scholar
• Takami Y, Ryu T, Wada Y, et al. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Sci. 2013;20(3):332–341. doi:10.1007/s00534-012-0527-5
   PubMed Web of Science ®Google Scholar
• Li W, Zhou X, Huang Z, et al. Short-term and long-term outcomes of laparoscopic hepatectomy, microwave ablation, and open hepatectomy for small hepatocellular carcinoma: a 5-year experience in a single center. Hepatol Res. 2017;47(7):650–657. doi:10.1111/hepr.12785
   PubMed Web of Science ®Google Scholar
• Zhang Q-B, Zhang X-G, Jiang R-D, et al. Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patients. Int J Hyperthermia. 2017;33(3):255–262. doi:10.1080/02656736.2016.1257824
   PubMed Web of Science ®Google Scholar
• Chong CCN, Lee K-F, Chu C-M, et al. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection. HPB. 2018;20(6):546–554. doi:10.1016/j.hpb.2017.12.001
   PubMed Web of Science ®Google Scholar
• Zheng H, Xu C, Wang X, et al. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm. Int J Hyperthermia. 2020;37(1):1345–1353. doi:10.1080/02656736.2020.1849825
   PubMed Web of Science ®Google Scholar
• Shi J, Sun Q, Wang Y, et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria. J Gastroenterol Hepatol. 2014;29(7):1500–1507. doi:10.1111/jgh.12572
   PubMed Web of Science ®Google Scholar
• Han J, Fan Y-C WK, Wang K. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2020;99(43):e22703. doi:10.1097/MD.0000000000022703
   PubMed Web of Science ®Google Scholar
• Spiliotis AE, Gäbelein G, Holländer S, et al. Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis. Radiol Oncol. 2021;55(3):247–258. doi:10.2478/raon-2021-0030
   PubMed Web of Science ®Google Scholar
• Xu HX, Xie XY, Lu MD, et al. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol. 2004;59(1):53–61. doi:10.1016/j.crad.2003.09.006
   PubMed Web of Science ®Google Scholar
• Lu M-D, Xu H-X, Xie X-Y, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40(11):1054–1060. doi:10.1007/s00535-005-1671-3
   PubMed Web of Science ®Google Scholar
• Shibata T, Shibata T, Maetani Y, et al. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology. 2006;238(1):346–353. doi:10.1148/radiol.2381041848
   PubMed Web of Science ®Google Scholar
• Ohmoto K, Yoshioka N, Tomiyama Y, et al. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. J Gastroenterol Hepatol. 2009;24(2):223–227. doi:10.1111/j.1440-1746.2008.05596.x
   PubMed Web of Science ®Google Scholar
• Simo KA, Sereika SE, Newton KN, et al. Laparoscopic-assisted microwave ablation for hepatocellular carcinoma: safety and efficacy in comparison with radiofrequency ablation. J Surg Oncol. 2011;104(7):822–829. doi:10.1002/jso.21933
   PubMed Web of Science ®Google Scholar
• Ding J, Jing X, Liu J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma. Eur J Radiol. 2013;82(9):1379–1384. doi:10.1016/j.ejrad.2013.04.025
   PubMed Web of Science ®Google Scholar
• Zhang XG, Zhang ZL, Hu SY, et al. Ultrasound-guided ablative therapy for hepatic malignancies: a comparison of the therapeutic effects of microwave and radiofrequency ablation. Acta Chir Belg. 2014;114(1):40–45. doi:10.1080/00015458.2014.11680975
   PubMed Web of Science ®Google Scholar
• Abdelaziz A, Elbaz T, Shousha HI, et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc. 2014;28(12):3429–3434. doi:10.1007/s00464-014-3617-4
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Farshid P, Naguib NNN, et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015;40(6):1829–1837. doi:10.1007/s00261-015-0355-6
   PubMedGoogle Scholar
• Yin X-Y, Xie X-Y, Lu M-D, et al. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115(9):1914–1923. doi:10.1002/cncr.24196
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang N, Shen Q, et al. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One. 2013;8(10):e76119. doi:10.1371/journal.pone.0076119
   PubMed Web of Science ®Google Scholar
• Huang Z, Guo Z, Ni J, et al. Four types of tumor progression after microwave ablation of single hepatocellular carcinoma of ≤5 cm: incidence, risk factors and clinical significance. Int J Hyperthermia. 2021;38(1):1164–1173. doi:10.1080/02656736.2021.1962548
   PubMed Web of Science ®Google Scholar
• Yoon JH, Goo YJ, Lim C-J, et al. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2020;26(32):4833–4845. doi:10.3748/wjg.v26.i32.4833
   PubMed Web of Science ®Google Scholar
• Lee SK, Lee SW, Jang JW, et al. Immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma. Int J Mol Sci. 2021;22(19):1.
   Web of Science ®Google Scholar
• Yu J, Cheng Z-G, Han Z-Y, et al. Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: a 12-year real-world, multicentric experience. Liver Cancer. 2022;11(4):341–353. doi:10.1159/000522134
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yu J, Liu S, et al. Multiparametric liver MRI for predicting early recurrence of hepatocellular carcinoma after microwave ablation. Cancer Imaging. 2022;22(1):42. doi:10.1186/s40644-022-00471-5
   PubMed Web of Science ®Google Scholar
• Dong T, Nie F, Liu T, et al. Different power modes microwave ablation of hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Asian J Surg. 2023. doi:10.1016/j.asjsur.2023.03.070
   Web of Science ®Google Scholar
• Zhang NN, Lu W, Cheng XJ, et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Clin Radiol. 2015;70(11):1237–1243. doi:10.1016/j.crad.2015.06.092
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen Y, Ye F, et al. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival. Eur Radiol. 2021;31(5):3053–3064. doi:10.1007/s00330-020-07460-x
   PubMed Web of Science ®Google Scholar
• Yang Y, Xin Y, Ye F, et al. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors. Int J Hyperthermia. 2021;38(1):437–446. doi:10.1080/02656736.2020.1849828
   PubMed Web of Science ®Google Scholar
• Kang TW, Lim HK, Lee MW, et al. Aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation: risk factors and clinical significance. Radiology. 2015;276(1):274–285. doi:10.1148/radiol.15141215
   PubMed Web of Science ®Google Scholar
• Song KD, Lee MW, Rhim H, et al. Aggressive intrasegmental recurrence of hepatocellular carcinoma after combined transarterial chemoembolization and radiofrequency ablation. Am J Roentgenol. 2016;207(5):1122–1127. doi:10.2214/AJR.16.16080
   PubMed Web of Science ®Google Scholar
• Yoon JH, Choi SK, Cho SB, et al. Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: a 15-year observational study. World J Gastroenterol. 2022;28(36):5351–5363. doi:10.3748/wjg.v28.i36.5351
   PubMed Web of Science ®Google Scholar
• You Y, Zhang M, Li K, et al. Feasibility of 3D US/CEUS-US/CEUS fusion imaging-based ablation planning in liver tumors: a retrospective study. Abdom Radiol. 2021;46(6):2865–2874. doi:10.1007/s00261-020-02909-5
   PubMed Web of Science ®Google Scholar
• Floridi C, Radaelli A, Pesapane F, et al. Clinical impact of cone beam computed tomography on iterative treatment planning during ultrasound-guided percutaneous ablation of liver malignancies. Med Oncol. 2017;34(6):113. doi:10.1007/s12032-017-0954-x
   PubMed Web of Science ®Google Scholar
• Taher H, Grasso V, Tawfik S, et al. The challenges of deep learning in artificial intelligence and autonomous actions in surgery: a literature review. Artif Intell Surg. 2022;2(3):144–158. doi:10.20517/ais.2022.11
   Google Scholar
• Fujiwara N, Friedman SL, Goossens N, et al. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68(3):526–549. doi:10.1016/j.jhep.2017.09.016
   PubMed Web of Science ®Google Scholar
• Cai Z, Su X, Qiu L, et al. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Mol Cancer. 2021;20(1):164. doi:10.1186/s12943-021-01467-8
   PubMed Web of Science ®Google Scholar
• Schemmer P, Burra P, Hu R-H, et al. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection. Liver Int. 2022;42(2):288–298. doi:10.1111/liv.15124
   PubMed Web of Science ®Google Scholar
• Zhou T, Liang X, Wang P, et al. A hepatocellular carcinoma targeting nanostrategy with hypoxia-ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence. ACS Nano. 2020;14(10):12679–12696. doi:10.1021/acsnano.0c01453
   PubMed Web of Science ®Google Scholar